AbbVie Affirms Q3 Adj EPS Guidance of $3.84-$3.88 vs $3.84 Est

Benzinga Newsdesk www.benzinga.com Positive 40.9%

Neg 0% Neu 0% Pos 40.9%

AbbVie (NYSE:ABBV) affirms Q3 Adj EPS guidance from $3.84-$3.88 to $3.84-$3.88 vs $3.84 analyst estimate..

Comments

No comments yet. Be the first!